High Court to weigh in on $26.3M Lexapro patent judgment
Angus Lang
2021-02-11 10:43 pm
| Melbourne
The High Court will decide whether the Full Court was wrong to overturn a $26.3 million judgment for Danish drug maker H Lundbeck in its long-running patent battle with generic drug maker Sandoz over the patent for blockbuster antidepressant Lexapro.
For information on rights and reprints, contact subscriptions@lawyerly.com.au